Researchers investigated the safety, efficacy, and treatment persistence of subcutaneous vedolizumab, compared with IV vedolizumab in IBD.

Researchers compared whether adalimumab drug clearance or concentration would better predict clinical outcomes in Crohn disease.

Opioid-free discharge is feasible after pancreatic surgery, according to a study published online Sept. 6 in JAMA Surgery.

The leading cause of hepatocellular carcinoma is still hepatitis C virus among men, but the rates of HCV-HCC have decreased since 2015.

Researchers examined geographic and population distributions of HIV-1 and HIV-1 circulating subtypes.

The FDA has approved the sNDA for Veklury to include COVID-19 treatment in patients with mild to severe hepatic impairment with no dose adjustments.

While health care providers understand the value of pneumococcal vaccination, there are knowledge gaps and implementation challenges with the recommendations.

AbbVie has submitted a regulatory application to the FDA seeking approval of risankizumab for treating moderately to severely active ulcerative colitis.

Researchers investigated whether removing a gastric adenoma would help prevent gastric cancer incidence and mortality.

Researchers sought to determine the magnitude of an association between gastroesophageal reflux disease and anxiety and depression.

For individuals with obesity undergoing bariatric surgery, depression is associated with higher inflammation before and after surgery.

For patients with inflammatory bowel disease, statin use is linked to a reduced risk for colorectal cancer (CRC) incidence and mortality.

A study was conducted to determine the probability of 5% or greater weight loss in US adults with initial obesity or overweight.

New data suggest that, from 1990 to 2019, the global incidence of early-onset cancer increased by nearly 80%, and the rate of early-onset cancer deaths increased by nearly 30%.

The Food and Drug Administration (FDA) has granted Fast Track designation to CBP-4888 for the treatment of preeclampsia.

The Advisory Committee on Immunization Practices has issued new guidelines for the prevention and control of seasonal influenza with vaccines for the 2023-2024 season.

Researchers investigated to what extent mental health disorders affect children and young adults with inflammatory bowel diseases.

Researchers sought to characterize disease activity among pediatric patients with inflammatory bowel disease.

The Kettles Esophageal and Cardia Adenocarcinoma predictioN Tool can predict incident esophageal adenocarcinoma and gastric cardia adenocarcinoma.

Short-term therapy with commonly used immunosuppressive drug classes and many drugs is not associated with an increased risk for cancer incidence.

A systematic review and meta-analysis explored the effects of a vegetarian diet on metabolic and anthropometric outcomes in individuals with overweight and obesity.

Treatment with seladelpar was associated with an improvement in cholestatis markers in patients with primary biliary cholangitis.

The FDA has cleared RELiZORB cartridge for use in pediatric patients aged 2 to less than 5 years old experiencing fat malabsorption.

Adding ipilimumab to treatment with nivolumab does not provide a clinically meaningful benefit in patients with certain cancers, a meta-analysis suggests.

Given limited prior research, investigators performed a large multicenter cohort study to examine the efficacy of tacrolimus induction therapy for UC.

Researchers investigated how ulcerative colitis symptoms affect QOL and the extent to which health care professionals are aware of patients’ reduced QOL.

In 2021, there were 3,035 reports of arthropod-borne viruses (arboviruses) in the United States, including 2,911 caused by West Nile virus.

Starting Wednesday, August 30, travelers to China will no longer need a negative COVID-19 test to enter that country.

In a cohort study, researchers assessed the relationship between SARS-CoV-2 infection and the development of Bell’s palsy.

Researchers estimated trends in SARS-CoV-2 seroprevalence in Canada from 2020 to 2023, comparing the prevaccination, vaccine rollout, and post-Omicron periods.